Services of MTRC

A value dossier is a document of a certain structure that summarizes in a comprehensive and unbiased way all value-related messages for medical technology. The unique approach of MTRC is based on a deep understanding of evidence and data presentation requirements for market access processes in a large number of European countries.

MTRC offers support with monitoring of medical information and/or clinical guidelines, data extraction from identified relevant sources and analysis (if relevant). Identified information can be stratified into different domains (e.g., epidemiology, clinical effectiveness, health economics). Search is performed primarily in the largest databases of medical publications, Medline and Medline In-Process.

This free webinar provides an overview of the comprehensive process to establish pathway-specific and fact-based evidence requirements for medical technologies to meet the requirements of reimbursement, funding and HTA authorities.

In August, MTRC launched two subscription services with a focus on all published, initiated or ongoing HTA and reimbursement reports and decisions for medical devices, procedures and IVD tests. HTA Alerts is a global service and covers 56 organizations from 24 countries. Reimbursement Alerts is focused on 14 key European countries. All alerts are tailed to the technologies of interest for each client. You can request a free-of-charge 2-month sample of reporting for both services

A syndicated report (135 pages) reviews details of innovation funding and coverage with evidence development schemes in Europe, including Austria, Belgium, England, France, Germany, the Netherlands, and Switzerland. For each scheme, information about objective, inclusion criteria, applicant, stakeholders involved, clinical and economic evidence requirements, and statistics (including at least 2019-2020 data; but for most schemes – statistics for multiple years) is included.

MTRC released an update of the syndicated report on reimbursement decisions for IVD tests in 5 EU countries (Belgium, France, Germany, the Netherlands, and Switzerland). The updated report covers 3-year period of 2018-2020. Broader coverage gives a better understanding of the activity of the reimbursement organizations.

In August, MTRC launched two subscription services with a focus on all published, initiated or ongoing HTA and reimbursement reports and decisions for medical devices, procedures and IVD tests. HTA Alerts is a global service and covers 56 organizations from 24 countries. Reimbursement Alerts is focused on 14 key European countries. All alerts are tailed to the technologies of interest for each client. You can request a free-of-charge 2-month sample of reporting for both services

In January 2021, we performed the first annual survey of our customers to synch with our internal knowledge about key developments in the area of market access in European countries. This brief (15 slides) report includes an overview of key developments of reimbursement systems in 2020 and anticipated changes in 2021. Ten countries are included: Belgium, Denmark, England, France, Germany, the Netherlands, Norway, Russia, Sweden and Switzerland.